GYKI 14166 - CAS 83997-16-4
Catalog number: 83997-16-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H30N6O3.H2O4S
Molecular Weight:
500.57
COA:
Inquire
Targets:
Thrombin
Description:
Efegatran is a thrombin inhibitor under the development of Eli Lilly. It can be used for the treatment of thromboembolic disorders. No development reported was reported for the treatment of Thrombosis.
Purity:
98%
Appearance:
Powder
Synonyms:
Efegatran;RGH2958; LY 294468; (S)-1-(D-phenylalanyl)-N-((S)-5-guanidino-1-oxopentan-2-yl)pyrrolidine-2-carboxamide sulfate
Solubility:
Soluble in DMSO
Storage:
-20℃ Freezer
MSDS:
Inquire
Application:
Thrombosis
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
RMYMBMLRPYLYDX-VNMUXGFYSA-N
InChI:
1S/C20H30N6O3.H2O4S/c21-16(12-14-6-2-1-3-7-14)18(28)25-19(29)17-9-5-11-26(17)15(13-27)8-4-10-24-20(22)23;1-5(2,3)4/h1-3,6-7,13,15-17H,4-5,8-12,21H2,(H4,22,23,24)(H,25,28,29);(H2,1,2,3,4)/t15-,16+,17-;/m0./s1
Canonical SMILES:
c1ccc(cc1)C[C@H](C(=O)NC(=O)[C@@H]2CCCN2[C@@H](CCCNC(=N)N)C=O)N.OS(=O)(=O)O
Current Developer:
Eli Lilly
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Thrombin Products


CAS 496775-62-3 Eltrombopag Olamine

Eltrombopag Olamine
(CAS: 496775-62-3)

Eltrombopag is a is an agonist of the c-mpl (TpoR) receptor used as treatment for thrombocytopenia.It has been developed for certain conditions that lead to thr...

CAS 429658-95-7 Dabigatran ethyl ester

Dabigatran ethyl ester
(CAS: 429658-95-7)

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity. Dabigatran provides a stable anticoagulation effect w...

CAS 872728-81-9 Dabigatran etexilate mesylate

Dabigatran etexilate mesylate
(CAS: 872728-81-9)

Dabigatran etexilate mesylate is the orally active prodrug of dabigatran. It is a reversible and selective, direct thrombin inhibitor (DTI).

CAS 137339-65-2 Sfllrnpndkyepf

Sfllrnpndkyepf
(CAS: 137339-65-2)

SFLLRNPNDKYEPF is a synthetic thrombin receptor agonist peptide and causes platelet aggregation (EC50 = 4 μM) and secretion .

Bivalirudin Trifluoroacetate

Bivalirudin is a specific and reversible bivalent direct thrombin inhibitor. Bivalirudin specifically binds to both the catalytic site and to the anion-binding ...

CAS 138068-37-8 Lepirudin

Lepirudin
(CAS: 138068-37-8)

Lepirudin is an anticoagulant that acts as a direct thrombin inhibitor. Lepirudin binds to both free and clot-bound thrombin. Lepirudin is approved for the trea...

CAS 211915-06-9 Dabigatran Etexilate

Dabigatran Etexilate
(CAS: 211915-06-9)

Dabigatran etexilate(BIBR-1048) is the orally active prodrug of dabigatran; Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki va...

CAS 74863-84-6 Argatroban

Argatroban
(CAS: 74863-84-6)

Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor.

CAS 30827-99-7 AEBSF HCl

AEBSF HCl
(CAS: 30827-99-7)

AEBSF is a water soluble, irreversible serine protease inhibitor; inhibits proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.

CAS 141396-28-3 Argatroban

Argatroban
(CAS: 141396-28-3)

Argatroban is an anticoagulant that is a direct thrombin inhibitor. Argatroban was approved in 2000 for prophylaxis or treatment of thrombosis in patients with ...

H-D-Phe-Pro-arginal
(CAS: 60503-05-1)

H-D-Phe-Pro-arginal is a thrombin inhibitor which is being developed by IVAX for the potential treatment of thromboembolic disorders. It has a similar efficacy ...

VE-1902

VE-1902 is a novel and selective inhibitor of thrombin. Study in vivo and in vitro showed that VE-1902 inhibits thrombin via binding to it reversibly.

CAS 871576-03-3 Flovagatran

Flovagatran
(CAS: 871576-03-3)

Flovagatran is a thrombin inhibitor originated by Trigen Holdings AG. In Dec 2010, Phase-II for Thrombosis was discontinued.

CAS 192939-46-1 Ximelagatran

Ximelagatran
(CAS: 192939-46-1)

Ximelagatran, an ester prodrug of melagatran, with anticoagulant effect, is the first member of direct thrombin inhibitors that can be taken orally.

GYKI14451
(CAS: 69201-89-4)

GYKI14451 is a synthetic tripeptide inhibitor of thrombin. It has anti-atherosclerotic activity.

CAS 137215-12-4 odiparcil

odiparcil
(CAS: 137215-12-4)

Odiparcil is a novel thrombin inhibitor as a beta-d-thioxyloside analog originated by Fournier Pharma. It is also a Glycosaminoglycan stimulant. Research for th...

GYKI-14451 sulfate
(CAS: 83861-29-4)

GYKI-14451 is a synthetic tripeptide inhibitor of thrombin.It has anti-atherosclerotic activity.

CAS 83997-16-4 GYKI 14166

GYKI 14166
(CAS: 83997-16-4)

Efegatran is a thrombin inhibitor under the development of Eli Lilly. It can be used for the treatment of thromboembolic disorders. No development reported was ...

CAS 211914-51-1 Dabigatran

Dabigatran
(CAS: 211914-51-1)

Dabigatran is a very potent anticoagulant, shows that the terminal phenyl can be substituted by the more hydrophilic 2-pyridyl group without substantial loss of...

Chemical Structure

CAS 83997-16-4 GYKI 14166

Quick Inquiry

Verification code

Featured Items